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Abstract
The absorption capacity of cotton dressings is a critical factor in their widespread use
where they help absorb wound exudate. Cotton wax dressings, in contrast, are used
for wounds where care is taken to avoid adhesion of dressings to sensitive wounds
such as burn injuries. Accordingly, we explored the loading of 2-deoxy-D-ribose
(2dDR), a small sugar, which stimulates angiogenesis and wound healing in normal
and diabetic rats, into both types of dressings and measured the release of it over
several days. The results showed that approximately 90% of 2dDR was released
between 3 and 5 days when loaded into cotton dressings. For wax-coated cotton
dressings, several methods of loading of 2dDR were explored. A strategy similar to
the commercial wax coating methodology was found the best protocol which pro-
vided a sustained release over 5 days.
Cytotoxicity analysis of 2dDR loaded cotton dressing showed that the dressing stim-
ulated metabolic activity of fibroblasts over 7 days confirming the non-toxic nature
of this sugar-loaded dressings. The results of the chick chorioallantoic membrane
(CAM) assay demonstrated a strong angiogenic response to both 2dDR loaded cotton
dressing and to 2dDR loaded cotton wax dressings. Both dressings were found to
increase the number of newly formed blood vessels significantly when observed mac-
roscopically and histologically.
We conclude this study offers a simple approach to developing affordable wound
dressings as both have the potential to be evaluated as pro-active dressings to stimu-
late wound healing in wounds where management of exudate or prevention of
adherence to the wounds are clinical requirements.
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1 | INTRODUCTION
In the development of wound dressings, the priorities are to provide a
safe barrier layer to ensure wound cover and to create an environ-
ment which is conducive to wound healing. Over the years, these
have been achieved with the use of a range of materials.
Wound dressings can be described as simple or advanced, and
there are many excellent reviews of the strategies for developing
these such as a recent review from Öhnstedt et al. (Öhnstedt, Lofton
Tomenius, Vågesjö, & Phillipson, 2019). The natural process of wound
healing can be delayed or arrested where there is a poor blood supply,
bacterial or fungal infection (particularly bacterial biofilms), and an
aggressive inflammatory environment (Thomas Hess, 2011). All of
these are most likely to occur in long-established, chronic non-healing
wounds. In other wounds such as acute surgical wounds or skin loss
due to burns or injuries, there is a need to prevent fluid and electro-
lyte loss and bacterial colonisation of wounds. For burn wounds, the
urgent need is to restore barrier function. Very superficial scalds can
heal well and rapidly if managed conservatively. Deeper burns and
full-thickness burns can be managed by the use of dermal substitutes
such as Integra whose main function is to provide a well-vascularised
dermal substrate to support skin grafts. This area has previously been
reviewed in detail (MacNeil, 2007). Unfortunately, such sophisticated
dressings are rarely available in some poorer countries. Hence in this
study, we selected a dressing currently in use for both chronic non-
healing wounds and burns wounds-specifically cotton fibre dressing
and petrolatum wax coated cotton dressings, respectively.
A critical step in wound healing is the production of new blood
vessels that deliver cells from the immune system to tackle infection
and to breakdown damaged tissues. Blood vessels also provide meta-
bolic support to the wound area via red blood cells that supply oxygen
and growth factors to stimulate tissue regeneration. (Tonnesen, Feng,
& Clark, 2000). Growth factors are released from the blood platelets,
which aggregate in the wound area. This process is regulated via the
production and release of a complex, highly-regulated series of
growth factors that help to drive new blood vessel formation. Vascu-
lar endothelial growth factor (VEGF) is recognised as a critical growth
factor. It is not only the most effective stimulator of angiogenesis but
also helps to regulate many of the different aspects of angiogenesis at
the molecular level (Ahluwalia & Tarnawski, 2012; Des Rieux
et al., 2011; Roman et al., 2002; Witzenbichler et al., 1998). In addi-
tion to VEGF, there is platelet-derived growth factor (PDGF) and
other pro-angiogenic growth factors which are generally produced on
demand and bound to naturally occurring heparin from which they are
cleaved as needed (Honnegowda et al., 2015). As expected, there
have been extensive studies on the use of these well-established
growth factors in wounds to accelerate healing (Nicosia, Nicosia, &
Smith, 1994; Pierce, Tarpley, Yanagihara, Fox, & Thomason, 1992).
Although their addition can accelerate wound healing, the results have
proven modest rather than dramatic, and it is thought that this is due
to the instability of these small peptides such that their biological
actions do not last very long. The practical consequence of this is that
growth factors need to be given every day or two days and indeed
current research is now looking at gene therapy approaches to turn
on the production of the growth factors when required (Öhnstedt
et al., 2019).
Our group and several others have recently published that
2-deoxy sugars have unexpectedly been found to drive angiogenesis.
This followed by the finding of a high level of 2 deoxy-D-Ribose
(2dDR) in tumour angiogenesis (Nakajima, Madhyastha, &
Maruyama, 2009). Accordingly, we defined the angiogenic concentra-
tions of 2dDR in vitro (Dikici et al., 2020) and in ex-ovo CAM assay
(Dikici, Mangır, Claeyssens, Yar, & MacNeil, 2019). Then, we further
investigated whether this small stable sugar could be added to con-
ventional wound dressings to drive angiogenesis. Our findings showed
that it could be easily loaded to hydrogels made of chitosan (Yar
et al., 2017) and alginate (Azam et al., 2019) and delivered from them
to stimulate angiogenesis.
Although we have shown that 2dDR can be loaded into a variety
of wound dressings, the challenge is to develop a dressing that is
widely available, inexpensive, and can deliver 2dDR to stimulate
angiogenesis and wound healing. Our study was based in Pakistan
where, unfortunately, more sophisticated dressings are simply not
available, and this is true for most of the less developed countries due
to economic reasons. Surgeons trained in the West are frustrated that
they cannot offer patients proactive dressings such as drug-releasing
dressings or hydrogels or dermal substitutes such as Integra in these
countries. Accordingly, in this study, we explored the potential of sim-
ple cotton fibre dressings in terms of delivering 2dDR. Throughout
this study, we partnered with Pakistani surgeons and a Pakistani
wound dressing company Cotton Craft. In addition to exploring the
angiogenic potential of 2dDR loaded simple cotton dressings, cotton
fibre dressings were also coated with medical-grade wax petrolatum
to reduce the adherence of them to wounds (Dhivya, Padma, &
Santhini, 2015; Olasupo Awe, 2019; Ramesh, Jayalakshmi, &
Mohan, 2017). Cotton Craft has prior experience in combining
established bioactives approved for clinical use with these petrolatum
wax dressings (e.g. Parachlore Tulle Gras which delivers chlorhexidine
acetate, a well-accepted antimicrobial disinfectant, and Poly Gras
Dressing Surgical Tulle Dressing which delivers polymyxin B sulphate
and Bacitracin Zinc, antibiotics to treat gram-negative and gram-
positive infections, respectively).
Simple bandaging materials have good absorption capacities to
absorb and trap exudates and act as a barrier to outside contaminants
and microorganisms as infection prevention (Turner, 1979). Nonwo-
ven fibrous wound dressings are considered an attractive option in
the management of moderately and highly exudative wounds because
of their absorption capacity, accessibility and low price (Dygai
et al., 2011). On the other hand, clinicians usually recommend paraffin
(wax)-coated dressings for partial-thickness burn wounds as they
work well when used with a secondary dressing. These dressings act
as a main wound contact layer, and the paraffin coating reduces the
dressing adherence to the wound surface. Moreover, these dressings
can effectively transfer the exudate from the wound surface through
the perforations into the secondary dressing, and these perforations
also allow one to inspect the wound through the dressing
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(Hassanpour, Moosavizadeh, Yavari, Hallaj Mofrad, & Fadaei, 2013).
Paraffin-coated gauze dressings are attractive candidates for the
treatment of partial and full-thickness wounds burn wounds and are
being used by plastic surgeons for the coverage of wounds as a stan-
dard skin graft donor site dressing (Olawoye, Ademola, Oluwatosin,
Iyun, & Michael, 2017).
In this study, we used two types of commercially available
cotton-based dressings: (i) cotton dressings covering a range of
absorptive capacities and (ii) wax-coated cotton dressing. Several
strategies were evaluated, and a straightforward methodology was
selected for loading 2dDR into the wax-coated dressing that would be
compatible with current manufacturing techniques. We assessed the
uptake and release of 2dDR from these dressings over five days and
were able to achieve approximately 90% release of sugar over five
days from both types of dressing. We then investigated the pro-
angiogenic activity of both the cotton fibre dressings and the cotton
fibre wax dressing in the CAM assay and found that both were
strongly pro-angiogenic. Quantification of angiogenesis showed that
the increase in blood vessels formed over 7 days ranged from 50%
when investigated macroscopically to 100% when investigated histo-
logically, respectively. Our results demonstrated that loading 2dDR
into commercially available cotton fibre dressings is a rapid, feasible,
and effective way of driving angiogenesis in a well-accepted CAM
bioassay.
2 | MATERIALS AND METHODS
2.1 | Materials
The cotton dressings (32 g/m2, 40 g/m2, 70 g/m2, and 150 g/m2), the
cotton fibre (lino fabric) dressings, hard wax, beeswax, petroleum jelly,
and liquid paraffin were provided by Cotton Craft Private Limited
(Lahore, Pakistan). 2-Deoxy-D-ribose (2dDR) and Orcinol mono-
hydrate (CH3C6H3–1,3-(OH)2.H2O) were purchased from Sigma-
Aldrich (China). Nutrient Agar broth was purchased from Microgen
(India). Ethanol (99.8%) was purchased from Sigma-Aldrich (Germany).
Ferric Chloride hexahydrate (FeCl3.6H2O) and hydrochloric acid (HCl)
were purchased from AnalaR NORMAPUR (United Kingdom), and
Merck (Germany) respectively. Glycerol was purchased from MERK
Pakistan Limited. MTT Cell Proliferation Assay Kit was purchased
from Bio Basic (USA).
2.2 | Methods
2.2.1 | Assessment of absorption capacities of
different non-woven cotton dressings
The absorption capacities of different non-woven cotton dressings
were determined by swelling them directly in PBS (phosphate buffer
saline) solution (pH 7.4) at room temperature for 30 minutes. For this
purpose, 20 × 20 mm2 patches of different non-woven cotton
dressings (32 g/m2, 40 g/m2, 70 g/m2, 150 g/m2) and cotton fibre
dressings were used. The weight of the dressings was measured
before immersion in PBS (dry weight) and after hydration in PBS (wet
weight). Based on their swelling behaviour as well as the dressing's
integrity 32 g/m2, 40 g/m2, 70 g/m2 and 150 g/m2 cotton dressings
were selected for further studies.
2.2.2 | Assessment of loading of 2dDR into the
cotton dressings
Pieces of selected non-woven cotton dressings of 20 × 20 mm2
(32 g/m2, 40 g/m2, 70 g/m2 and 150 g/m2) were cut, autoclaved and
placed at 37C overnight to remove moisture. 1.85 mg of 2dDR (cal-
culated as 5 wt% of dressing) prepared in sterilized PBS medium was
dropped onto each sterilized dressing and allowed to air-dry in aseptic
condition.
Loading of 2dDR and wax coating onto cotton dressings
The woven cotton dressings used in this study were lino fabric dress-
ings in which cotton was processed into very thin fibres. The
20 × 20 mm2 pieces of lino fabric dressings were cut, autoclaved and
placed at 37C overnight to remove moisture. Seven different strate-
gies were carried out for introducing 2dDR into the wax coating to
achieve a sugar release from wax-coated lino fabric dressing which
will be called as cotton wax dressings throughout the manuscript.
These strategies included the use of other carriers for sugar or the
addition of an extra component in the wax mixture to decrease the
sugar linkage with wax or by the surface coating of sugar onto the
dressings. These strategies are explained below.
Strategy 1: 2dDR loading and wax coating using liquid paraffin as a sugar
carrier. The aim of this protocol was that each 20 × 20 mm2 piece of
dressing should contain 1.85 mg of 2dDR (1.85 mg/20 × 20 mm2 car-
rier dressing) as at this concentration, we have previously shown that
2dDR was effective in a diabetic rat model (Azam et al., 2019). In the
current strategy, two mixtures were prepared. Mixture A was pre-
pared by heating the ingredients hard wax (1.15% w/w), beeswax
(1.15% w/w) and petroleum jelly (97.7% w/w) at around 50C temper-
ature. This mixture A was used as a stock in other wax coating strate-
gies given below. Mixture B was prepared by dissolving 18.5 mg of
2dDR into liquid paraffin (200 mg) by heating and vigorous stirring at
around 65C temperature. For the preparation of 10 pieces of
20 × 20 mm2 dressings, mixture B (18.5 mg 2dDR in 200 mg liquid
paraffin) was mixed with 500 mg of mixture A at around 50C, and a
homogenous final mixture was obtained. The 10 pieces of
20 × 20 mm2 dressings were dipped into the final mixture and allowed
to air-dry in aseptic conditions following the original industrial recipe
of Cotton Craft PTV. LTD.
Strategy 2: Surface coating of the dressings with 2dDR using ethanol as a
sugar carrier. In this strategy, the 10 sterile (autoclaved) 20 × 20 mm2
pieces of cotton gauze dressings were taken and dipped into 500 mg
ANDLEEB ET AL. 3
of mixture A (stock mixture prepared above in strategy 1) at 50C and
then allowed to air-dry in aseptic conditions to produce the wax-
coated dressings. Then 2dDR (18.5 mg) was dissolved in ethanol
(1,000 μl) (instead of liquid paraffin), and this was called as mixture C.
The wax-coated 10 dressings were dipped into the mixture C, to
achieve a surface coating of these dressings with 2dDR.
Strategy 3: Polyethylene glycol (PEG) addition using liquid paraffin as a
sugar carrier. The methodology of Strategy 3 was similar to Strategy
1, but PEG was added to the sugar carrier solution (liquid paraffin). To
achieve this PEG (100 mg) was dissolved in liquid paraffin (200 mg) by
heating and continuous mixing, and then 2dDR (18.5 mg) was added
to the mixture and dissolved via vigorous stirring at around 60C tem-
perature, this was called as the mixture D. The mixture D was then
mixed with 500 mg of mixture A taken from the stock wax mixture as
prepared above in Strategy 1. The rest of the procedure of dressing
preparation and wax coating was performed following the same steps
as Strategy 1.
Strategy 4: PEG addition and diluting the wax mixture to decrease 2dDR
retention in the dressing. This strategy was similar to Strategy 3, except
that the amount of liquid paraffin used was doubled (400 mg).
Strategy 5: Surface coating of sugar using liquid paraffin as a sugar car-
rier. In this strategy, 10 wax-coated dressings (20 × 20 mm2) were pre-
pared by dipping in 500 mg of mixture A (taken from the stock
prepared in Strategy 1) at 50C, and air-dried at room temperature.
Then these dressings were dipped into mixture B as prepared in Strat-
egy 1. Finally, they were allowed to air-dry in aseptic conditions.
Strategy 6: Addition of PEG and surface coating of sugar using liquid par-
affin as a sugar carrier. This strategy was similar to Strategy 5. The only
difference was that the prepared wax-coated dressings were dipped
into mixture D as prepared in Strategy 3 instead of mixture B.
Strategy 7: Diluting the wax mixture to decrease 2dDR entrapment in the
dressing. In this strategy, the overall method was the same as for Strat-
egy 1 (original industrial recipe), but the amount of liquid paraffin was
doubled to 400 mg. In this way, overall, a 20 × 20 mm2 wax-coated
dressing took up an average of 1.85 mg 2dDR. All further steps of the
wax coating were performed as in Strategy 1.
2.2.3 | Assessment of release of 2dDR from
dressings
2dDR release from non-woven cotton dressings
The accumulative release of 2dDR from 32 g/m2, 40 g/m2, 70 g/m2
and 150 g/m2 cotton dressings was determined using Bial's orcinol
assay. The sugar-loaded 20 × 20 mm2 pieces of the dressings were
immersed in 4 ml of PBS solution and incubated at 37C. The medium
was collected and replaced by fresh PBS after 4 hours and afterwards
daily until the medium showed no significant drug release. Bial's assay
was performed to confirm 2dDR presence in the collected medium as
described previously (Patterson & Mura, 2013). Briefly, 4 ml volume
of the collected sample solution and the same amount of Bial's
reagent (a solution of orcinol, HCl and ferric chloride) was placed in
falcon tubes. The solution was incubated in a boiling water bath for
20 minutes. The heated sample was then removed from the water
bath and allowed to cool at room temperature. The sample tubes were
centrifuged to sediment any particulate material and absorbance was
measured at 630 nm using a UV–VIS spectrophotometer. Absorbance
values were converted into concentrations using a standard curve of
known concentrations of 2dDR.
Following opinions received from the plastic surgeons with whom
we are collaborating, the 150 g/m2 cotton dressing from among the
non-woven dressings was selected for further studies. The 150 g/m2
cotton dressing was chosen for its use in chronic and exuding wounds
because of its fabric integrity, smoothness, lightweight, high strength
and best absorption capacity.
2dDR release from cotton wax dressings
The accumulative release of 2dDR over 5 days from wax-coated
dressings (gamma sterilized at 25 kG) of all sugar loading strategy
groups was determined using Bial's orcinol assay as given above.
2.2.4 | The effect of glycerol treatment on the
release profile of 2dDR
After the absorption of wound exudate, the dressing may become dry,
which would disturb the peri-wound area and cause pain to the
patient. We aimed to minimize the dressing roughness after absorp-
tion of wound exudate through the addition of glycerol onto wax-
coated dressings. The effect of glycerol coating on the rate of 2dDR
release from dressings was also determined. Briefly, the effect of glyc-
erol on moisture retention and sugar release from wax-coated dress-
ings were studied by treating the dressings with 4% glycerol solution
(prepared in distilled water). For this purpose, 20 × 20 mm2 patches
of wax-coated dressings (n = 6) were prepared according to strategy
7. Half of the dressings were treated with glycerol (glycerol treated
group) while the other half were taken as the control group. For glyc-
erol treatment, 5% 2dDR loaded cotton wax dressings were dipped in
4% glycerol solution and allowed to dry in a sterile environment. Sugar
release studies from both the groups (control and glycerol treated)
were performed using Bial's orcinol assay as previously described, and
the difference in sugar release behaviour from both the groups was
calculated.
2.2.5 | SterilizationTest
The sterility of the 5% 2dDR loaded 150 g/m2 cotton dressings and
5% 2dDR loaded cotton wax dressings was ensured by performing
diffusion disk tests before and after gamma sterilization at 25 kG. For
this purpose, 5% 2dDR loaded patches with and without gamma
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sterilization from both dressing groups were prepared. The study was
divided into two sections (5% 2dDR loaded 150 g/m2 cotton dressing
and 5% 2dDR loaded cotton wax dressing) each having three groups
(control, dressings without gamma sterilization and dressings after
gamma sterilization). Briefly, nutrient broth medium and nutrient agar
medium were prepared and autoclaved. 10 ml of nutrient broth
medium was taken in test tubes, dressings from both sections were
immersed in it and placed at 37C for 24 hours. The experiment was
performed in triplicate, and a petri dish with broth medium without
any dressing was used as a control. After 24 hours incubation at 37C,
250 μl of broth medium was taken from all groups and spread on agar
plates and left overnight at 37C. The agar plates were carefully
examined for microbial growth after 24 hours and were compared for
the sterilities of the dressings.
2.2.6 | Cytotoxicity testing of 2dDR loaded
150 g/m2 dressings using MTT assay
To evaluate the cytotoxicity of 150 g/m2 cotton dressings,
NIH/3 T3 mouse fibroblast cell lines were used. MTT
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
was performed in which dressings were placed in indirect contact
with fibroblasts using transwell plates. Briefly, fibroblasts were
seeded into the base of 24 well transwell plates at a density of
2 × 104 cells/well in 15% FBS supplemented high glucose
Dulbecco's Modified Eagle Medium (DMEM-HG), and the plates
were incubated in a 5% CO2 humidified incubator at 37C. gamma
sterilized dressings were placed above the cells in the transwell
plates so that they were submerged in the same media as the cells
but not in direct contact. The culture media was regularly changed
every 2 days throughout the experiment duration. The metabolic
activities of fibroblasts in indirect contact with all 3 groups (tissue
culture plastic (TCP), 150 g/m2 control dressing, 5% 2dDR con-
taining 150 g/m2 cotton dressing) at day 3 and day 7 were exam-
ined by MTT assay (MTT cell proliferation assay kit, Bio Base,
USA) according to the manufacturer instructions (Wiegand, Abel,
Hipler, & Elsner, 2019). The optical density of each group was
recorded at a wavelength of 630 nm using an ELISA (Biorad) plate
reader. DMSO was taken as standard. The results for each group
were compared by statistical analysis.
2.2.7 | Assessment of the angiogenic potential of
dressings using the chick chorioallantoic membrane
(CAM) assay
Angiogenic activity of 5% 2dDR loaded 150 g/m2 cotton dressing
The angiogenic activity of 5% 2dDR loaded 150 g/m2 cotton
dressing was evaluated using the CAM assay over 7 days (Mangir,
Dikici, Claeyssens, & MacNeil, 2019), and non-loaded 150 g/m2
cotton dressing was used as a control throughout the experiments.
Ten embryos were used for each group, and the experiment was
carried out under sterile conditions. Briefly, fertilized chicken eggs
were purchased from Big Bird Industry (Lahore, Pakistan) and incu-
bated at 37C in a humidified egg incubator. At day 7, an area of
about 1 cm2 in the form of a square window was cut and removed
from the shell. Less than 1 cm2 pieces of dressings from both
groups were cut and implanted onto the CAM by inserting these
through the square window. The shell window was covered with
parafilm (disinfected by immersing into 70% ethanol prior to use)
and sealed with adhesive tape. After implantation, eggs were ret-
urned to a humidified egg incubator and incubated at 37C until
day 14. At day 14, the shell windows were opened carefully,
images were captured using camera and dressings were retrieved
for further evaluation.
Angiogenic activity of 5% 2dDR loaded cotton wax dressing
B2 twb=.4w?>The angiogenic potential of 5% 2dDR loaded cotton
wax dressings was assessed using the same protocol as described
above.
2.2.8 | Histological evaluation of the cotton
dressings
The dressings were histologically evaluated using hematoxylin–
eosin staining (H&E) of the sections retrieved from either cotton
dressings (non-loaded or loaded with 5% of 2dDR) or cotton wax
dressings (non-loaded or loaded with 5% of 2dDR). In brief, the
retrieved dressings from the CAM containing newly formed vascu-
lar networks were fixed in 10% paraformaldehyde solution and
embedded in paraffin for block preparation. The paraffin blocks
were sectioned using a microtome at a thickness of 5 μm, and the
sections were stained with H&E, as described previously (Aldemir
Dikici, Dikici, Reilly, MacNeil, & Claeyssens, 2019).
2.2.9 | Quantification of angiogenesis
For quantification of the angiogenesis from macroscopic images of
the blood vessels, a semi-quantitative assessment method was per-
formed by observers who were blind to the samples presented to
them using a qualitative grading scale: 0 = not angiogenic,
1 = weakly angiogenic, 2 = mildly angiogenic, 3 = moderately
angiogenic, 4 = highly angiogenic, 5 = very highly angiogenic. At
least seven embryos were used for each group studied. Represen-
tative images of the dressings were obtained from all seven
embryos and were assessed and scored by five researchers who
were not informed of the conditions used in each embryo.
For quantification of the angiogenesis from histological staining
of the sections, images were taken with a digital camera coupled
to the microscope and were analysed by rating the extent of blood
vessels formed in each group. The total number of blood vessels
adjacent to the dressings were quantified by counting blood ves-
sels in H&E sections, as described previously (Dikici, Mangır,
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et al., 2019; Mangir et al., 2019). Briefly, all discernible blood ves-
sels adjacent to the dressings were counted using a light micro-
scope at 10 × magnification.
2.2.10 | Statistical analysis
Statistical analyses were performed by one-way analysis of vari-
ance (ANOVA) test followed by unpaired Bonferroni test. For the
analysis of the CAM assay results, unpaired t-test with Welch's
correction was used. P < 0.05 was considered to be statistically
significant, and the data were expressed as means ± SD.
3 | RESULTS
3.1 | Swelling properties of different non-woven
dressings
Swelling studies of non-woven cotton dressings (32 g/m2, 40 g/m2,
70 g/m2, and 150 g/m2) and cotton fibre dressings were carried
out by immersing them directly in PBS for 30 minutes, and by
measuring their wet weight. The appearance of the dressing's pre
and post liquid absorption is shown in Figure 1a. All the dressings
showed good absorption capacity, whereas cotton fibres and
150 g/m2 took up considerably more liquid than the others, as
shown in Figure 1b. Based on their integrity, smoothness and their
state when wet, 32 g/m2, 40 g/m2, 70 g/m2 and 150 g/m2 cotton
dressings were selected for drug release studies. The simple cotton
fibre dressing was excluded because of its loose fibrous nature
which may cause undesired attachment to the wound.
Figure 2 shows the pictures of 150 g/m2 cotton dressing and cot-
ton wax dressings loaded with 5% 2dDR showing their flexibilities and
abilities to be folded.
3.2 | Release of 2dDR from non-woven cotton
dressings
A representative image that shows the qualitative evaluation of 2dDR
release over 5 days from 150 g/m2 cotton dressing, which was
selected for further studies is given in Fig. 3 Aa. The blue colour indi-
cates the presence of 2dDR in the solution. The change of colour from
blue to yellow over 5 days demonstrated that there was less release
of sugar after this point (Fig. 3 Aa). The graph in Fig. 3 Ab shows the
cumulative release of 5% 2dDR (1.85 mg/20 × 20 mm2 patches)
loaded into 32 g/m2, 40 g/m2, 70 g/m2, and 150 g/m2 non-woven
cotton dressings. The in vitro sugar release profile showed that
32 g/m2 cotton dressing gave an average sugar release of 255 μg/day
whereas the release of 2dDR was 616 μg/day and 566 μg/day from
40 g/m2 and 70 g/m2 cotton dressings, respectively. For all of the
dressings given above (32 g/m2, 40 g/m2, and 70 g/m2), almost all
(>90%) of the loaded sugar was released within 3 days. On the other
hand, 150 g/m2 cotton dressing showed a more sustained release pro-
file of 2dDR over 5 days with an average release of 370 μg/day.
3.3 | Release of 2dDR from cotton wax dressings
Fig. 3 Ba shows the cumulative release of 2dDR (1.85 mg/20 × 20 mm2
patches) loaded into wax-coated cotton dressings using different strat-
egies. The in vitro drug release profile showed that in strategy 1 (the
F IGURE 1 Figure (a) shows swelling studies of different non-woven cotton dressings (32 g/m2, 40 g/m2, 70 g/m2, and 150 g/m2) and cotton
fibre dressings. The figure shows their appearance before and after immersion in PBS for 30 minutes. Based on integrity, smoothness and their
wet state 32 g/m2, 40 g/m2, 70 g/m2, and 150 g/m2 cotton dressings were selected for further studies. Figure (b) shows a graphical
representation of the extent of weight gained by these dressings after PBS absorption. *** P ≤ 0.001, n = 3 ± SD [Colour figure can be viewed at
wileyonlinelibrary.com]
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original industrial recipe), no sugar release was observed from the
dressings until at least 7 days. When strategy 2 (surface coating of
sugar using ethanol as a drug carrier) and strategy 3 (PEG addition in
the original recipe for wax coating) were used for loading 2dDR, an
average sugar release of 1850 μg/day and 1800 μg/day was observed,
respectively. In strategy 4 (PEG addition in the diluted wax mixture),
the average drug release was slightly less, and it was measured as
1,500 μg/day. The use of strategy 5 (surface coating of sugar using liq-
uid paraffin as a drug carrier) and strategy 6 (PEG addition and surface
coating of sugar using liquid paraffin as a drug carrier) resulted in a com-
parably lower daily 2dDR release profile with an average of 314 μg/day
and 280 μg/day, respectively. Similar to strategy 5 and 6, in strategy
7 (diluting the wax mixture to decrease 2dDR entrapment), an average
drug release of 334 μg/day was measured. The 2dDR release
F IGURE 2 Pictures of
150 g/m2 cotton dressing and
cotton wax dressings loaded with
5% 2dDR showing their flexibility
and ability to be folded [Colour
figure can be viewed at
wileyonlinelibrary.com]
F IGURE 3 The release of 2dDR was
assessed using Bial's orcinol assay is
shown in Figure (A). Figure (Aa) shows
colorimetric detection of 2dDR released
from 150 g/m2 + 2dDR (5%) dressing to
the medium using Bial's orcinol assay and
(Ab) shows the cumulative release of
2dDR (1.85 mg/20 × 20 mm2 patches)
from different non-woven cotton
dressings (32 g/m2 dressing + 2dDR (5%),
40 g/m2 dressing + 2dDR (5%), 70 g/m2
dressing + 2dDR (5%), and 150 g/m2
dressing + 2dDR (5%)). The release
profiles from wax-coated cotton fibre
dressings are given in Figure (B).
Figure (Ba) shows the cumulative release
of 2dDR from cotton fibre dressings
prepared using different strategies.
Strategy 2,3, and 4 showed a similar
release behaviour which was very quick in
1 day while strategy 5,6, and 7 gave a
more sustained release pattern in 5 days.
No release was observed from dressings
wax-coated using strategy
1. Figure (Bb) shows the comparison of
2dDR release from 5% 2dDR loaded
cotton wax dressings with and without
glycerol treatment [Colour figure can be
viewed at wileyonlinelibrary.com]
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behaviours of the wax-coated cotton dressings using different strate-
gies are summarised inTable 1.
In strategies 2, 3 and 4, almost all of the loaded 2dDR (>90%) was
released within 1 day (in 24 hours). As a sustained release is required
from these dressings to stimulate wounds, these strategies were
excluded from future experiments. With the use of strategy 5, a better
release profile was obtained, and the loaded sugar was released
throughout 5 days. However, this strategy was also excluded because
it is more complicated for industry to manage one setup for wax coat-
ing and a separate setup for the sugar coating of dressings. Similarly,
strategy 6 gave a good release behaviour over 5 days, but this strat-
egy was also excluded due to the complexity of introducing it to
industry and secondly, it requires the addition of an extra component
of PEG to stimulate sugar release.
Finally, strategy 7 was found to be the best strategy of these pro-
tocols because of its sustained sugar release over 5 days, and it fol-
lows the same production procedure as the original industrial recipe
without the addition of any extra components such as PEG or ethanol
to achieve a better sugar release profile from the dressing.
3.4 | The efficiency of glycerol treatment on
moisture retention and sugar release profile in 2dDR
loaded cotton wax dressing
The effect of glycerol treatment on the release behaviour of loaded
sugar from the cotton wax dressings was evaluated by treatment with
4% glycerol solution prepared in distilled water. The evaluation of the
release profile of 2dDR from cotton wax dressings either non-treated
or treated with glycerol demonstrated that the glycerol treatment of
the 5% 2dDR loaded cotton wax dressings resulted in slightly slower
release of sugar (non-significant) over 6 days compared to 5% 2dDR
loaded cotton wax dressings which were not treated with glycerol as
shown in Fig. 3Bb.
3.5 | Confirmation of the sterility of 150 g/m2
cotton dressing and cotton wax dressing
To confirm the sterility of the gamma sterilised 5% 2dDR loaded
150 g/m2 cotton dressing and 5% 2dDR loaded cotton wax dressing,
these were incubated in Nutrient broth for 24 hours. In the case of
the sterility test performed on dressings without gamma sterilization,
microbial growth was observed on the agar plates after 24 hours from
both dressing groups when compared with the control, which indi-
cated that the dressings were not sterile. The sterilisation of the
dressings after gamma treatment was verified as no bacterial growth
was observed on the agar plates after 24 hours incubation at 37C
(Figure 4a).
3.6 | Cytotoxicity testing of 150 g/m2 dressing using
MTT assay
The MTT assay results performed using 150 g/m2 cotton dressing are
shown in Figure 4b. The dressings did not show any evidence of
TABLE 1 Strategies for loading 2dDR into cotton wax dressings. The number of “+” indicates the effectiveness of the respective strategy
when the ease of manufacturing and the release behaviour were considered. “+++” = very effective, “++” = effective, “+” = less effective, and
“-” = not effective
Strategy Ingredients Loading Method
Release
Duration
Release
(μg/day) Reasons for rejection/selection Effectiveness
1 Wax mixture Liquid
paraffin 2dDR
2dDR was dissolved in liquid
paraffin and mixed into
melted wax mixture
No release
over
5 days
0 No 2dDR release was observed
over 5 days
−
2 Wax mixture
Ethanol 2dDR
Surface coating of 2dDR using
ethanol as a sugar carrier
1 day 1850 The release of all the loaded
2dDR was too quick
+
3 Wax mixture Liquid
paraffin PEG
2dDR
PEG was added to liquid
paraffin as a sugar carrier
1 day 1800 The release of all the loaded
2dDR was too quick
+
4 Wax mixture Liquid
paraffin PEG
2dDR
PEG was added to increased
quantity of liquid paraffin as a
sugar carrier
1 day 1,500 The release of all the loaded
2dDR was too quick
+
5 Wax mixture Liquid
paraffin 2dDR
Surface coating of 2dDR using
liquid paraffin as a sugar
carrier
5 days 314 Good sustained release profile
was obtained, but it required
two coating steps
++
6 Wax mixture Liquid
paraffin PEG
2dDR
Surface coating of 2dDR using
PEG added liquid paraffin as a
sugar carrier
5 days 280 Good sustained release profile
was obtained, but it required
two coating steps
++
7 Wax mixture Liquid
paraffin 2dDR
Diluted wax mixture was used
by increasing the amount of
liquid paraffin (sugar carrier)
5 days 334 Good sustained release profile
was obtained using a coating
protocol corresponding to the
original recipe used in
industry
+++
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cytotoxicity. Indeed, cells showed higher metabolic activity when cul-
tured in indirect contact with the 5% 2dDR loaded 150 g/m2 cotton
dressings group compared to other groups. MTT assay results at both
days 3 and 7 demonstrated higher cell viability with sugar-containing
dressing compared to control. The results suggested that the released
2dDR over several days gradually increased cell proliferation.
3.7 | Assessment of the angiogenic potential of
dressings using the chick chorioallantoic membrane
(CAM) assay
Figure 5A shows that 5% 2dDR loaded 150 g/m2 cotton dressing
stimulated a much greater degree of angiogenesis compared to the
dressing without 2dDR, with a rich vascular network surrounding the
dressing placed on the CAM.
Similarly, the 5% 2dDR loaded cotton wax dressing induced sig-
nificantly more blood vessels as compared to the simple gauze dress-
ing without wax and 2dDR. Macro images and graphical
representations of the extent of angiogenesis for both groups are
shown in Figure 5B.
The results of the H&E staining of CAMs treated with the
150 g/m2 cotton dressing, and cotton wax dressing are given in
Figure 6. The control dressing without 2dDR showed only a few blood
vessels (Figure 6A) close to the area of implantation whereas the 5%
2dDR loaded 150 g/m2 cotton dressing induced a large number of
blood vessels with blood cells and inflammatory cells within them as
shown in Fig. 6Ab and 6Ac. Moreover, a dense connective tissue
network was seen in the 2dDR containing group as compared to the
control group. Graphical representation of the number of vessels
detected in H&E stained images from both groups is shown in Fig. 6A.
Blood vessels are indicated with red-headed arrows in the stained
images.
The addition of 5% 2dDR to cotton wax dressings induced the
formation of more blood vessels, as shown in Figure 6b compared to
its respective control dressing (Fig. 6 Ba). Fig. 6 BC shows the graphical
representation of the number of vessels present in H&E stained
images from both groups.
5% 2dDR loaded 150 g/m2 cotton dressing resulted in increased
angiogenesis on the CAM compared to the 5% 2dDR loaded cotton
wax dressing this was most evident when the extent of new blood
vessels was determined through histological evaluation of the cotton
dressings retrieved from the CAM as shown in Figure 6.
4 | DISCUSSION
Wounds are complex in nature, and no single universal dressing is
available, which can treat all types of wounds effectively
(Rajendran, 2010). The selection of the most appropriate wound
dressing for a particular wound not only depends on its type but
also on its stage, and more importantly, it requires clinical assess-
ment and specialist recommendation and knowledge (Uzun, 2018).
Many medical dressings are expected to possess hydrophilic prop-
erties with enhanced ability to take up wound fluid (Lionelli &
Lawrence, 2003). The dressings with good sorption capacity are
F IGURE 4 Figure (a) shows the sterility testing of 5% 2dDR loaded 150 g/m2 cotton dressing and cotton wax dressing using Nutrient Agar
plates. The figure shows the sterility test of control (simple broth used without any dressing), sterility test of dressings without gamma
sterilization and after irradiation with gamma rays. In case of dressings without gamma sterilization, the agar plates showed contamination due to
microbial growth, whereas no microbial growth was found on the agar plates when gamma sterilized dressings were used. Figure (b) shows the
assessment of cytotoxicity of dressings using MTT assay performed on 150 g/m2 cotton dressing. The graph shows the extent of cell viability in
TCP (simple cells plated on tissue culture plate without any dressing), control dressing (150 g/m2 cotton dressing without 2dDR) and 5% 2dDR
loaded 150 g/m2 cotton dressing groups at 3rd day and 7th day. “ns” represent non-significance in cotton dressing group vsTCP after both 3rd
day and 7th day. ***P ≤ 0.001 in 5% 2dDR loaded 150 g/m2 cotton dressing group vsTCP and control dressing after both 3rd day and 7th day.
Results presented as mean ± SD, n = 3 [Colour figure can be viewed at wileyonlinelibrary.com]
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considered more suitable for chronic wounds, including diabetic
wounds and burn ulcers, where exudate production is a major
issue (Cullen, Smith, Mcculloch, Silcock, & Morrison, 2002). In the
current study, all the non-woven cotton wound dressings (32 g/m2,
40 g/m2, 70 g/m2, and 150 g/m2) showed good absorption capac-
ity as depicted by their swelling behaviour in PBS in 30 minutes.
In addition, 150 g/m2 cotton dressing, not only demonstrated good
absorption capacity, but also had a smooth surface, and the dress-
ing was more resilient to handling compared to other cotton dress-
ings. Because of its ability to take up liquid efficiently, this
dressing could have the potential to be used for chronic exudative
wounds.
F IGURE 5 Assessment of the angiogenic potential of 5% 2dDR loaded 150 g/m2 cotton dressing and cotton wax dressing using the CAM
assay: The dressings were placed into the fertilized eggs at day 7 of fertilization. The figure (A) shows the pictorial illustration of control dressing
(150 g/m2 cotton dressing without sugar) and 5% 2dDR loaded 150 g/m2 cotton dressing on the embryo at day 14 of fertilization. The picture
(Aa, Ab) shows the original CAM macro-vasculature, (Ac, Ad) shows their respective processed images using image J. and (Ae, Af) shows the
respective explanted dressings. The figure (Ag) shows the graphical representation of the rate of angiogenesis for both control dressing and 5%
2dDR loaded 150 g/m2 cotton dressing usingT-test analysis. Similarly, the figure (B) shows the pictorial illustration of cotton wax dressing
(control dressing) and 5% 2dDR loaded cotton wax dressing on the embryo at day 14 of fertilization. The picture (Ba, Bb) shows the original CAM
macro-vasculature, (Bc, Bd) shows their respective processed images using image J. and (Be, Bf) shows the respective explanted dressings. The
figure (Bg) shows the graphical representation of the rate of angiogenesis out of 5 for both control dressing and 5% 2dDR loaded cotton wax
dressing usingT-test analysis. A rich vascular network was observed in the groups treated with 5% 2dDR loaded 150 g/m2 cotton dressing and
cotton wax dressing as compared to their respective control dressings. However, 2dDR loaded 150 g/m2 cotton dressing have shown
significantly more angiogenesis as compared to 2dDR loaded cotton wax dressing. Results presented as mean ± SD, n = 8 [Colour figure can be
viewed at wileyonlinelibrary.com]
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Burn wounds are challenging to manage because they can be
highly exudative and often have a large surface area. Burn patients
also experience a lot of pain if dressings adhere to the wound bed,
and this may cause secondary trauma when the dressings are
removed (Gosselin & Kuppers, 2008; Kim et al., 2014). Wax-coated
dressings have been widely used as burn wound dressing materials
due to their smooth texture which reduces adhesion to the wound
bed (Thomas, 1994). Various conventional gauze dressings such as
Jelonet (Smith & Nephew Healthcare Limited, Watford, UK), Adaptic
(Johnson & Johnson Medical, New Jersey, United States), and Mepitel
(Mölnlycke Health Care, Gothenburg, Sweden) with perforated or
open mesh structure have long been used for the treatment of burn
wounds (Hassanpour et al., 2013). A clinical study reported the effi-
cacy of paraffin gauze dressings in comparison with dry mesh gauze
dressings and reported that the former resulted in more rapid and
complete re-epithelialization (Martini, Reali, Borgognoni, Brandani, &
Andriessen, 1999). Moreover, patients with paraffin gauze dressings
reported less pain during dressing removal than when treated with
dry mesh gauze dressings (Weber et al., 1995).
Accordingly, in this study, we compared seven wax coating strate-
gies for introducing 2dDR into the wax-coated cotton dressings for
wounds that require a treatment where less-adherent wound dress-
ings are used. Our findings showed that strategy 7, a strategy very
similar to the original commercial wax coating methodology (protected
as proprietary property of Cotton Craft), was found to be the most
effective method when the ease of manufacturing and the release
behaviour were considered.
Angiogenesis is an essential stage of the normal wound healing
process, but chronic wounds have impaired angiogenesis because of
inadequate blood supply hence less local growth factors which are
crucial to driving angiogenesis. This results in delayed wound healing
(Honnegowda et al., 2015). Promoting neovascularisation in the
F IGURE 6 Histological analysis of CAM assay retrieved dressings: The figure (Aa) shows hematoxylin–eosin staining of control dressing and
(Ab) shows staining of 5% 2dDR loaded 150 g/m2 cotton dressing, (c) shows cross-section of image depicting the blood vessel containing red
blood cells along with infiltrated inflammatory cells (infiltration of inflammatory cells occur from connective tissue bed into the blood vessels)
while (Ad) shows graphical representation of comparison of number of blood vessels present in the H&E stained images from both 150 g/m2
cotton dressing and 5% 2dDR loaded 150 g/m2 cotton dressing using T-test analysis. Similarly, the figure (Ba) shows hematoxylin–eosin staining
of control dressing, (Bb) shows staining of 5% 2dDR loaded cotton wax dressing and (Bc) shows the graphical representation of the comparison of
number of blood vessels present in the H&E stained images from both control dressing and 5% 2dDR loaded cotton wax dressing usingT-test
analysis. A considerable increase in blood vessel formation (shown by redheaded arrows) was observed in the groups treated with 5% 2dDR
loaded 150 g/m2 cotton dressing and cotton wax dressing as compared to their respective control dressings. However, 2dDR loaded 150 g/m2
cotton dressing have resulted in more blood vessels as compared to 2dDR loaded cotton wax dressing. Results presented as mean ± SD, n = 6
[Colour figure can be viewed at wileyonlinelibrary.com]
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wound area can be induced by the local delivery of growth factors,
chemical mediators and endothelial cell chemoattractants (Tonnesen
et al., 2000). Amongst these approaches, the use of pro-angiogenic
agents is widely-studied, and many researchers have tried to manipu-
late these pro-angiogenic components to improve healing in experi-
mental wound models (Hoeben et al., 2004).
VEGF is recognised as a critical factor in promoting angiogenesis
(Hoeben et al., 2004). ECs are sensitive to VEGF signalling, which
mediates proliferation, migration and survival of them (Olsson,
Dimberg, Kreuger, & Claesson-Welsh, 2006; Wang et al., 2008). How-
ever, despite the effectiveness of VEGF in inducing angiogenesis, the
use of exogenous VEGF in an uncontrolled manner has previously
been reported to result in the promotion of leaky (Yancopoulos
et al., 2000), permeable (Cao et al., 2004) and haemorrhagic (Cheng,
Nagane, Huang, & Cavenee, 1997) blood vessels. Thus, the use of
alternative pro-angiogenic agents to ensure neovascularisation in
wound healing is essential.
2dDR is one of the degradation products of thymidine to thy-
mine, which is produced in vivo by the catalytic action of thymidine
phosphorylase (TP), and it has previously been reported as an
angiogenesis-inducing factor in vitro and in vivo (Sengupta, Sellers,
Matheson, & Fan, 2003) and an endothelial-cell chemoattractant
(Brown & Bicknell, 1998). As a local delivery approach, the pro-
angiogenic potential of 2dDR has recently been reported by our group
in vitro (Dikici, Aldemir Dikici, et al., 2020), in an ex ovo CAM bioassay
(Dikici, Mangır, et al., 2019), and in the acceleration of wound healing
in both normal wounds (Yar et al., 2017) and diabetic wounds in rats
(Azam et al., 2019). Although the mechanism of action of 2dDR is still
unclear, the current literature focuses on two potential pathways:
(i) the intracellular production of 2dDR by degradation of thymidine to
thymine induces oxidative stress and stimulates the secretion of
angiogenic factors such as VEGF and interleukin-8 to promote angio-
genesis (Brown, Jones, Fujiyama, Harris, & Bicknell, 2000; Nakajima
et al., 2009; Sengupta et al., 2003) and (ii) 2dDR activates NADPH oxi-
dase 2 which triggers the activation of nuclear factor-kappa B to
upregulate the VEGF receptor 2 expression (Vara et al., 2018).
Previous studies of our group demonstrated that 2dDR is an effective
and inexpensive alternative to VEGF for promoting angiogenesis. Our
prior works exploring 2dDR for promoting angiogenesis and wound
healing are summarised inTable 2.
In the present work, 2dDR is added to commercially available
cotton-based dressings. The 2dDR release studies from non-woven
cotton dressings showed that the sugar release profile from 32 g/m2,
40 g/m2, and 70 g/m2 cotton dressings was rapid with almost all the
loaded sugar (>90%) released from the dressings within 3 days. This is
an expected outcome since the dressings with lower weights per
square meter have a relatively higher surface area where 2dDR is
released from, as can be seen in Figure 1. An average release of
592 μg/day, 660 μg/day, and 566 μg/day were observed over 3 days
from 32 g/m2, 40 g/m2, and 70 g/m2 cotton dressing, respectively.
The 2dDR release behaviour from 150 g/m2 cotton dressing was
more sustained up to 5 days. This is more likely due to having a lower
liquid contact area as the weight of this dressing per square meter
area is higher than the others. However, the burst release of 2dDR
was observed in 2–3 days (the average release of 2dDR was
370 μg/day). We have previously demonstrated that a similar release
profile of 2dDR from commercially available alginate dressing not only
stimulated angiogenesis but also improved wound healing in diabetic
rats (Azam et al., 2019). In addition, a very similar release behaviour
has previously been observed when 2dDR was released from
electrospun polymer nanofibres to stimulate angiogenesis in ex-ovo
CAM assay (Dikici, Mangır, et al., 2019). This release pattern is appro-
priate for wounds where the dressing is changed once or twice a
week (Saghazadeh et al., 2018).
The release profiles from cotton wax dressings prepared using
different sugar loading strategies are summarised in Table 1. The dif-
ferent strategies to load 2dDR into wax-coated cotton gauze dress-
ings has resulted in different release behaviour of 2dDR because of
different components used in the procedures. In strategy 1 (original
industrial recipe), no drug release was observed because 2dDR was
tightly entrapped in highly viscous wax coating on the dressings. In
strategy 2, when the wax-coated cotton dressing was dipped into
TABLE 2 A summary of our prior works exploring the use of 2dDR for promoting angiogenesis and wound healing. “n/a” corresponds to not
applicable
Assay The type of carrier explored
Effective doses
of 2dDR Result References
In vitro n/a 100 μM to 1 mM Promotes endothelial proliferation,
migration and tube formation
(Dikici, Aldemir Dikici,
et al., 2020)
In-ovo
CAM
Chitosan/collagen hydrogel 1 mg/ml Promotes angiogenesis (Yar et al., 2017)
Cotton dressings (non-woven and wax
coated cotton dressings)
5 and 10% (w/w) this study
Ex-ovo
CAM
n/a 200 μg/day (Dikici, Mangır, et
al., 2019)Electrospun polymer nanofibres 250 μg/1 g
polymer
In vivo Chitosan/collagen hydrogel 1 mg/ml Promotes angiogenesis and wound healing
in healthy rats
(Yar et al., 2017)
Alginate Dressing 5 and 10% (w/w) Promotes angiogenesis and wound healing
in diabetic rats
(Azam et al., 2019)
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2dDR solution in ethanol, it resulted in an abrupt release in one day
because 2dDR was superficially coated on the wax surface after etha-
nol was evaporated. In order to facilitate the release of 2dDR from
wax, PEG was used in strategies 3, 4 and 6. PEG being polar and solu-
ble in water was added along with 2dDR drug, with the concept it
might push 2dDR release from wax by binding itself with 2dDR. As a
result, Strategies 3 and 4 resulted in burst release and over 1 day all
the 2dDR was released. In strategy 6, a sustained release was
observed over 5 days, when 2dDR solution in PEG and liquid paraffin
was coated on wax dressing. However, due to this involving two
steps, this procedure was not very attractive. In strategy 5, 2dDR
release was observed over 5 days, and drug release was stimulated
from wax dressings by coating 2dDR direct on wax surface of dress-
ings via dipping wax-coated dressings in 2dDR containing drug carrier
solution in liquid paraffin. However, like strategy 6, this was again two
steps and not attractive. The best protocol for loading sugar into wax-
coated dressings was found to be strategy 7 where we managed to
obtain a sustained release of 2dDR over 5 days by following the same
procedure of the original industrial recipe without the addition of any
extra components such as PEG or ethanol. In this strategy, double the
proportion of liquid paraffin was used, which was diluted to give the
final coating mixture and hence stimulated the sustained release of
2dDR from dressings. This method of 2dDR loading into the wax-
coated dressings showed an average release of 334 μg/day over
5 days.
After the application of a dressing to a wound, following absorp-
tion of wound exudate, the dressing may become dried out and
develop a rough texture which could disturb the wound area and
cause pain to the patient (Dabiri, Damstetter, & Phillips, 2016). Addi-
tion of glycerol to the wound dressings may be helpful to avoid this
situation by giving softness to the dressings even after these become
dried out (Stout & McKessor, 2012). To test the effect of glycerol on
moisture retention and sugar release profile in 2dDR loaded cotton
wax dressing, the dressings were treated with a 4% aqueous solution
of glycerol and left to dry in aseptic conditions. The 2dDR release
studies showed glycerol treatment resulted in slightly slower sugar
release (over 7 days) compared to untreated 2dDR loaded cotton wax
dressings. Thus, glycerol treatment of dressings can also be consid-
ered because of the softness it brings to these dressings.
The in vitro cytotoxicity assay results demonstrated that there
were no adverse effects of these dressings on fibroblast survival.
Indeed, the presence of the 2dDR stimulated the metabolic activity of
these cells over 7 days. Similarly, we have recently reported that the
treatment of 2dDR increases the metabolic activity of cells in a dose-
dependent manner (Dikici, Aldemir Dikici, et al., 2020).
The sterilisation of the dressings was confirmed for two reasons.
It is essential for their future clinical translation, and it is necessary to
prevent contamination of the chick embryos. If a standard method of
sterilisation such as gamma radiation had either affected the release
of the sugar from the dressing or its biological activity, then this would
have been a major problem in the development of the dressing for
future clinical use. Hence, our desire to check this out early. Luckily,
standard gamma radiation did not affect sugar release or the biological
activity of the sugar-loaded dressings in our previous studies in which
alginate was used (Azam et al., 2019), and now, in this study, we have
confirmed that gamma sterilisation can be effectively used with cot-
ton dressings.
The second point is that the CAM assay is a very good bioassay
to evaluate the angiogenic properties of the biomaterials, but the liv-
ing chick embryo is highly sensitive to infection. Thus, the sterility of
the material to be implanted on CAM and the cleanness of the equip-
ment used are critically important not only for the survival rate of the
embryos but also for the reliability of the results (Dikici, Claeyssens, &
MacNeil, 2019; Dikici, Mangır, et al., 2019; Mangir et al., 2019).
The inclusion of 2dDR in both 150 g/m2 cotton dressings and
cotton wax dressings stimulated angiogenesis either when assessed
macroscopically (quantified using photographs of the CAMs) or histo-
logically (quantified based on the histological sections of the CAMs).
The histological analysis of the CAMs showed increased blood vessel
formation adjacent to the area where the dressings were implanted.
The macroscopic evaluation of the CAMs also showed that there were
more blood vessels in the 5% 2dDR loaded 150 g/m2 cotton dressing
when compared to controls. Figure 6A- 6B show the connective tis-
sue bed having various cells, including inflammatory cells and blood
cells. In Fig. 6 Ac inflammatory cells can be seen along with red blood
cells inside the blood vessel. The presence of inflammatory cells in
blood vessels of CAM during angiogenesis has previously been
reported (Bessa et al., 2015). Inflammatory cells are essential activa-
tors of neoangiogenesis via production of cytokines, vascular endo-
thelial growth factor, interleukins (IL-1, IL-2, and IL-8) and platelet
activator factor. All of these are cell-specific growth factors, and they
play vital roles in the initiation of the inflammatory response, which
ultimately leads to neovascularisation and growth of pre-existing cap-
illaries in the CAM (Zijlstra et al., 2006).
Our findings clearly showed the angiogenic potential of both
2dDR loaded cotton dressing and cotton wax dressings where a sig-
nificantly higher angiogenic response was observed for 2dDR loaded
150 g/m2 cotton dressings. Despite this difference, the main finding
is that both dressings are effective at stimulating angiogenesis.
5 | CONCLUSIONS
In conclusion, the introduction of 2dDR into non-woven cotton
wound dressings and wax-coated cotton dressings achieved good
angiogenic potential in a well-accepted angiogenic bioassay. This is in
line with our previous studies in which we have used various biomate-
rials for the delivery of 2dDR to promote angiogenesis. 5% 2dDR
loaded 150 g/m2 cotton dressing and 5% 2dDR loaded cotton wax
dressings showed similar sugar release kinetics over 5 days. Thus, one
could choose either dressing for clinical development depending on
the wound type. The former dressing would be ideal for treating
chronic wounds and ulcers because of its good absorption capacity,
while the 2dDR containing cotton wax dressing would be preferable
for treating burn wounds because of its non-adhesive properties. Both
dressings are based on cotton fibre dressings manufactured in
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Pakistan and supplied to various hospitals throughout Pakistan. Thus,
there is potential to develop these as effective advanced wound
dressings that could be developed for clinical use in Pakistan and
indeed in any countries where access to low-cost pro-angiogenic
dressings would be beneficial.
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